Free Trial

Induction Healthcare Group (INHC) Competitors

Induction Healthcare Group logo
GBX 5.60 -0.40 (-6.67%)
As of 03/28/2025 12:16 PM Eastern

INHC vs. COG, FDBK, TRLS, IQAI, DVRG, SENS, EMIS, CRW, INS, and KOO

Should you be buying Induction Healthcare Group stock or one of its competitors? The main competitors of Induction Healthcare Group include Cambridge Cognition (COG), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Induction Healthcare Group vs.

Induction Healthcare Group (LON:INHC) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership.

Cambridge Cognition has higher revenue and earnings than Induction Healthcare Group. Cambridge Cognition is trading at a lower price-to-earnings ratio than Induction Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Induction Healthcare Group£12.57M0.41-£5.12M-£5.54-1.01
Cambridge Cognition£15.64M1.02-£1.58M-£3.76-10.10

Cambridge Cognition received 91 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%

Induction Healthcare Group has a beta of -0.41, meaning that its share price is 141% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

46.3% of Induction Healthcare Group shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 54.6% of Induction Healthcare Group shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cambridge Cognition has a net margin of -10.07% compared to Induction Healthcare Group's net margin of -40.70%. Induction Healthcare Group's return on equity of -26.97% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Induction Healthcare Group-40.70% -26.97% -7.32%
Cambridge Cognition -10.07%-68.83%-0.30%

In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company Overall Sentiment
Induction Healthcare Group Neutral
Cambridge Cognition Neutral

Summary

Cambridge Cognition beats Induction Healthcare Group on 8 of the 13 factors compared between the two stocks.

Remove Ads
Get Induction Healthcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INHC vs. The Competition

MetricInduction Healthcare GroupHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£5.17M£204.15M£5.63B£2.61B
Dividend YieldN/A6.68%4.59%4.82%
P/E Ratio-1.01239.4723.37141.38
Price / Sales0.41502.93387.84283,159.35
Price / Cash2.6847.1438.1728.02
Price / Book0.295.216.894.62
Net Income-£5.12M-£15.55M£3.20B£5.81B
7 Day Performance-6.67%-2.41%-2.99%1.42%
1 Month Performance-13.85%-7.70%1.63%7.35%
1 Year Performance-63.87%3.15%9.45%112.38%

Induction Healthcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INHC
Induction Healthcare Group
N/AGBX 5.60
-6.7%
N/A-63.9%£5.17M£12.57M-1.0174Gap Down
COG
Cambridge Cognition
N/AGBX 38
-2.6%
N/A-32.4%£15.91M£15.64M-10.1080
FDBK
Feedback
N/AGBX 17.64
+1.4%
N/A-86.9%£7.73M£3.88M-0.7124High Trading Volume
TRLS
Trellus Health
N/AGBX 1.57
-1.6%
N/A-3.6%£3.04M£65,831.01-0.4631Gap Up
IQAI
IQ-AI
N/AGBX 0.93
-1.1%
N/A-36.3%£2.06M£538,190.00-13.676Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.786 of 5 stars
GBX 1,880
+1.1%
GBX 2,800
+48.9%
-18.4%£807.77M£230.77M69.46734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 130.90
+1.5%
GBX 583.33
+345.6%
-51.3%£48.04M£50.72M12.30478
Remove Ads

Related Companies and Tools


This page (LON:INHC) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners